NT-ProBNP Levels in Saliva and Its Clinical Relevance to Heart Failure

• Jared Yong Yang Foo,

  Affiliation The Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Brisbane, Queensland, Australia

  ⨯
• Yunxia Wan,

  Affiliation The Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Brisbane, Queensland, Australia

  ⨯
• Karam Kostner,

  Affiliations School of Medicine, University of Queensland, Brisbane, Queensland, Australia, Department of Cardiology, Mater Adult Hospital, Brisbane, Queensland, Australia

  ⨯
• Alicia Arivalagan,

  Affiliations School of Medicine, University of Queensland, Brisbane, Queensland, Australia, Department of Cardiology, Mater Adult Hospital, Brisbane, Queensland, Australia

  ⨯
• John Atherton,

  Affiliations School of Medicine, University of Queensland, Brisbane, Queensland, Australia, Department of Cardiology, Royal Brisbane and Women’s Hospital, Brisbane, Queensland, Australia

  ⨯
• Justin Cooper-White,

  Affiliations The Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Brisbane, Queensland, Australia, School of Chemical Engineering, University of Queensland, Brisbane, Queensland, Australia

  ⨯
• Goce Dimeski,

  Affiliations School of Medicine, University of Queensland, Brisbane, Queensland, Australia, Chemical Pathology, Princess Alexandra Hospital, Brisbane, Queensland, Australia

  ⨯
• Chamindie Punyadeera

  * E-mail: c.punyadeera@uq.edu.au

  Affiliations The Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Brisbane, Queensland, Australia, School of Chemical Engineering, University of Queensland, Brisbane, Queensland, Australia

  ⨯